Feng Wang

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Radical Prostatectomy

Neuroendocrine Tumors

Top Venues

Contrast media & molecular imaging

Journal of the Endocrine Society

OncoTargets and therapy

EJNMMI research

This page only lists publications with an associated author ORCID identifier.

Publications

Rui Tian, Xiaochen Yao, Jieping Song, Jun Wang, Jingjing Fu, Liang Shi, Fei Yu, Pengjun Zhang, Chuan Zhang, Yudan Ni, Feng Wang
Anlotinib for Metastatic Progressed Pheochromocytoma and Paraganglioma: A Retrospective Study of Real-World Data. Journal of the Endocrine Society 8 (6) (2024)
Rui Tian, Xiaochen Yao, Jieping Song, Jun Wang, Jingjing Fu, Liang Shi, Fei Yu, Pengjun Zhang, Chuan Zhang, Yudan Ni, Feng Wang
Anlotinib for Metastatic Progressed Pheochromocytoma and Paraganglioma: A Retrospective Study of Real-World Data. Journal of the Endocrine Society 8 (6) (2024)
Rui Tian, Xiaochen Yao, Jieping Song, Jun Wang, Jingjing Fu, Liang Shi, Fei Yu, Pengjun Zhang, Chuan Zhang, Yudan Ni, Feng Wang
Anlotinib for Metastatic Progressed Pheochromocytoma and Paraganglioma: A Retrospective Study of Real-World Data. Journal of the Endocrine Society 8 (6) (2024)
Rui Tian, Qing Xie, Fei Yu, Changzhi Du, Xiaochen Yao, Shiming Zang, Chuan Zhang, Pengjun Zhang, Guoqiang Shao, Zhi Yang, Feng Wang, Jiangyuan Yu
Detection of Bone Metastases by 68 Ga-DOTA-SSAs and 18 F-FDG PET/CT: A Two-Center Head-to-Head Study of Gastroenteropancreatic Neuroendocrine Neoplasms. Contrast media & molecular imaging 2022 (2022)
Nuo Yi, Yajing Wang, Shiming Zang, Lulu Yang, Hao Liu, Hongbin Sun, Liwei Wang, Feng Wang
Ability of 68 Ga-PSMA PET/CT SUVmax to differentiate ISUP GG2 from GG3 in intermediate-risk prostate cancer: A single-center retrospective study of 147 patients. Cancer medicine (2022)
Jingjing Fu, Fan Qiu, Cati Raluca Stolniceanu, Fei Yu, Shiming Zang, Yili Xiang, Yue Huang, Milovan Matovic, Cipriana Stefanescu, Qiyun Tang, Feng Wang
Combined use of 177 Lu-DOTATATE peptide receptor radionuclide therapy and fluzoparib for treatment of well-differentiated neuroendocrine tumors: A preclinical study. Journal of neuroendocrinology 34 (4) (2022)
Jingjing Fu, Yan Xie, Tong Fu, Fan Qiu, Fei Yu, Wei Qu, Xiaochen Yao, Aiping Zhang, Zhenhua Yang, Guoqiang Shao, Qingle Meng, Xiumin Shi, Yue Huang, Wei Gu, Feng Wang
[99mTc]Tc-Galacto-RGD2 integrin αvβ3-targeted imaging as a surrogate for molecular phenotyping in lung cancer: real-world data. EJNMMI research 11 (1) (2021)
Liang Shi, Shuxian An, Ying Liu, Jianjun Liu, Feng Wang
PCK1 Regulates Glycolysis and Tumor Progression in Clear Cell Renal Cell Carcinoma Through LDHA. OncoTargets and therapy 13 (2020)
Le-Le Zhang, Wen-Cheng Li, Zheng Xu, Nan Jiang, Shi-Ming Zang, Lu-Wei Xu, Wen-Bing Huang, Feng Wang, Hong-Bin Sun
68Ga-PSMA PET/CT targeted biopsy for the diagnosis of clinically significant prostate cancer compared with transrectal ultrasound guided biopsy: a prospective randomized single-centre study. European journal of nuclear medicine and molecular imaging 48 (2) (2020)
Guoqiang Shao, Yue-Bing Wang, Xianzhong Liu, Meili Zhao, Jinhua Song, Peiling Huang, Feng Wang, Zizheng Wang
Investigation of Newly Prepared Biodegradable 32P-chromic Phosphate-polylactide-co-glycolide Seeds and Their Therapeutic Response Evaluation for Glioma Brachytherapy. Contrast media & molecular imaging 2018 (2018)
Yue-Bing Wang, Guoqiang Shao, Jianping Wu, Can Cui, Shimin Zang, Fan Qiu, Ruipeng Jia, Zizheng Wang, Feng Wang
Preparation of 68Ga-PSMA-11 with a Synthesis Module for Micro PET-CT Imaging of PSMA Expression during Prostate Cancer Progression. Contrast media & molecular imaging 2018 (2018)